|
NVCT Nuvectis Pharma Inc 1875558 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-6,050,000.00 |
| Balance Sheet |
|
Current Assets
|
$25,398,000.00 |
|
Assets
|
$25,398,000.00 |
|
Current Liabilities
|
$11,178,000.00 |
|
Liabilities
|
$11,178,000.00 |
|
Equity
|
$14,220,000.00 |
|
Shares Out
|
26525533.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,511,000.00 |
| Market Analysis |
Market Cap
|
$603,721,131.08 |
|
Price
|
$22.24 |
|
BVPS
|
0.54 |
|
PB
|
42.15 |
|
EPS
|
-0.26 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:28 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-11 |
-1.32 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-05 |
-0.26 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-0.30 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NVCT documents filed with the SEC.
NVCT Filings
Clear
